Center, 2012, International variation in prostate cancer incidence and mortality rates, Eur Urol, 61, 1079, 10.1016/j.eururo.2012.02.054
Yossepowitch, 2007, The natural history of noncastrate metastatic prostate cancer after radical prostatectomy, Eur Urol, 51, 940, 10.1016/j.eururo.2006.10.045
James, 2015, Survival with newly diagnosed metastatic prostate cancer in the “docetaxel era”: data from 917 patients in the control arm of the STAMPEDE trial (MRC PR08, CRUK/06/019), Eur Urol, 65, 1028, 10.1016/j.eururo.2014.09.032
Gratzke, 2014, Role of radical prostatectomy in clinically non-organ-confined prostate cancer, Curr Urol Rep, 15, 455, 10.1007/s11934-014-0455-9
Mickisch, 2001, Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial, Lancet, 358, 966, 10.1016/S0140-6736(01)06103-7
Flanigan, 2001, Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer, N Engl J Med, 345, 1655, 10.1056/NEJMoa003013
Bristow, 2002, Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis, J Clin Oncol, 20, 1248, 10.1200/JCO.20.5.1248
Culp, 2014, Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study, Eur Urol, 65, 1058, 10.1016/j.eururo.2013.11.012
Gratzke, 2014, Role of radical prostatectomy in metastatic prostate cancer: data from the Munich Cancer Registry, Eur Urol, 66, 602, 10.1016/j.eururo.2014.04.009
Sooriakumaran, 2014, Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes, BMJ, 348, g1502, 10.1136/bmj.g1502
Psaila, 2009, The metastatic niche: adapting the foreign soil, Nat Rev Cancer, 9, 285, 10.1038/nrc2621
Ceelen, 2014, Surgery, wound healing, and metastasis: recent insights and clinical implications, Crit Rev Oncol Hematol, 89, 16, 10.1016/j.critrevonc.2013.07.008
Hong, 2015, Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer, Nat Commun, 6, 6605, 10.1038/ncomms7605
Gundem, 2015, The evolutionary history of lethal metastatic prostate cancer, Nature, 520, 353, 10.1038/nature14347
Chapin, 2014, Is treatment of the primary tumor in metastatic prostate cancer justified?, Eur Urol, 65, 1067, 10.1016/j.eururo.2013.12.011
Tewari, 2012, Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy, Eur Urol, 62, 1, 10.1016/j.eururo.2012.02.029
Heidenreich, 2015, Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study, J Urol, 193, 832, 10.1016/j.juro.2014.09.089
Sweeney, 2014, Impact on overall survival (OS) with chemohormonal therapy versus hormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa): an ECOG-led phase III randomized trial, J Clin Oncol, 32, LBA2, 10.1200/jco.2014.32.18_suppl.lba2
Gakis, 2014, The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature, Eur Urol, 66, 191, 10.1016/j.eururo.2013.05.033
Heidenreich, 2014, EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer, Eur Urol, 65, 467, 10.1016/j.eururo.2013.11.002
Surcel, 2015, Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey, BJU Int, 115, 571, 10.1111/bju.12796
Musch, 2008, Complications of pelvic lymphadenectomy in 1,380 patients undergoing radical retropubic prostatectomy between 1993 and 2006, J Urol, 179, 923, 10.1016/j.juro.2007.10.072
Heidenreich, 2014, EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—update 2013, Eur Urol, 65, 124, 10.1016/j.eururo.2013.09.046
Treiyer, 2011, A single center prospective study: prediction of postoperative general quality of life, potency and continence after radical retropubic prostatectomy, J Urol, 185, 1681, 10.1016/j.juro.2010.12.052